Icariin is a naturally occurring flavonoid compound extracted from plants in the Epimedium genus, commonly known as horny goat weed. It’s the primary active ingredient in Epimedium extracts, which have been used in traditional Chinese medicine for over 2,000 years to treat impotence and support sexual health. Today, icariin attracts research interest for a broader range of effects, from bone health to brain protection, though most evidence still comes from animal and lab studies rather than human trials.
Where Icariin Comes From
Icariin is found in several species of Epimedium, a flowering plant in the barberry family. The three main species used as sources are E. brevicornum, E. koreanum, and E. sagittatum. In supplement form, it’s typically sold as a standardized Epimedium extract listing the percentage of icariin on the label, or occasionally as an isolated compound.
Chemically, icariin is a flavonol glycoside, meaning it’s a plant pigment molecule with sugar groups attached. Its molecular formula is C₃₃H₄₀O₁₅, giving it a molecular weight of about 677. Those sugar groups play an important role in how your body processes it, as gut bacteria strip them off before the compound can be absorbed.
How Icariin Works in the Body
The most studied mechanism involves a signaling pathway that relaxes blood vessels. Icariin increases levels of a molecule called cGMP in smooth muscle tissue. cGMP is the same molecule targeted by prescription erectile dysfunction drugs: it causes blood vessels to widen and smooth muscle to relax. Icariin raises cGMP levels by inhibiting PDE5, the enzyme that breaks cGMP down.
In lab studies, icariin inhibits PDE5 with an IC50 (the concentration needed to block half the enzyme’s activity) of roughly 0.43 to 1.0 micromolar, depending on the specific PDE5 subtype tested. That makes it about one-tenth as potent as sildenafil. Its metabolite icariside II is considerably stronger, reaching about 50% of sildenafil’s potency. One synthetic derivative, 3,7-bis(2-hydroxyethyl) icaritin, matched sildenafil almost exactly in lab tests, with an IC50 of 75 nanomolar compared to sildenafil’s 74.
Beyond blocking the enzyme directly, icariin also reduces the genetic expression of PDE5 in tissue over time, particularly the PDE5A1 subtype. This suggests it could have both immediate and longer-term effects on blood flow, though this has only been confirmed in animal models.
What Happens After You Take It
Icariin doesn’t survive your gut intact. Within about an hour, bacteria in your intestines strip away its sugar molecules, converting it first to icariside II and then to smaller compounds called icaritin and desmethylicaritin. This transformation happens quickly, and most icariin is converted to icariside II before it’s even absorbed.
This matters because the compounds your body actually absorbs are different from the icariin you swallowed. Icaritin and desmethylicaritin, the end products of gut metabolism, have their own biological activity, including effects on estrogen receptors. One specific gut bacterium, Blautia sp. MRG-PMF1, is responsible for producing these further metabolites. That means your individual gut bacteria composition could influence how much benefit you get from an icariin supplement, though this hasn’t been tested directly in clinical settings.
Effects on Bone Health
Icariin has a dual effect on bone: it promotes the activity of cells that build new bone while simultaneously suppressing the cells that break bone down. On the building side, it activates several signaling pathways that stimulate bone-forming cells and increases the production of key structural proteins like collagen type I and BMP-2 (a protein that triggers new bone growth). On the breakdown side, it inhibits a signaling process called RANKL-induced osteoclast differentiation, which is the mechanism that activates bone-dissolving cells.
Animal studies across multiple types of bone loss, including models of postmenopausal osteoporosis, steroid-induced bone loss, age-related decline, and diabetic bone loss, consistently show that icariin improves both bone density and the internal architecture of bone tissue. No large human clinical trials have confirmed these results, but the consistency across different animal models is notable.
Brain and Cognitive Effects
Icariin activates the BDNF/TrkB pathway, a signaling system that supports the growth and survival of brain cells and strengthens connections between neurons. In rat models of vascular dementia (cognitive decline caused by poor blood flow to the brain), icariin treatment increased the production of proteins associated with synaptic plasticity, the brain’s ability to form and strengthen connections. It also reduced inflammatory markers in the hippocampus, the brain region most critical for memory.
These neuroprotective effects have been described in several animal studies, and icariin is classified as having both neuroprotective and mild estrogen-like activity. The estrogen-like effects may partly explain the brain benefits, since estrogen plays a protective role in brain health. However, human studies on cognitive outcomes remain limited.
Effects on Testosterone and Sexual Health
In a study using middle-aged rats whose reproductive systems were chemically damaged, icariin treatment improved the condition of reproductive organs and increased circulating testosterone levels. The compound is often described as having “testosterone mimetic” properties, meaning it produces some effects that resemble those of testosterone without being a hormone itself.
The combination of PDE5 inhibition (which improves blood flow) and hormonal effects gives icariin a two-pronged mechanism relevant to sexual function. Traditional use has centered on this application for centuries, and it remains the most common reason people seek out icariin supplements today.
Safety and Drug Interactions
Icariin itself has a relatively mild interaction profile. It does not inhibit the major liver enzymes (CYPs) that metabolize most prescription drugs. However, the picture gets more complicated when you account for what happens in the gut.
Icariin and its gut metabolites can inhibit certain enzymes in the intestinal wall called UGTs, which help process and eliminate many drugs. Icariin blocks intestinal UGT1A3, while its metabolite icariside II potently inhibits UGT1A4, and icaritin strongly inhibits UGT1A7. Based on calculated ratios, all three of these inhibitions are likely to occur in the intestine after a standard oral dose of Epimedium extract. In practical terms, this means icariin could slow the intestinal processing of other drugs you take at the same time, potentially increasing their absorption or effects.
The good news is that icariin and its metabolites reach very low concentrations in the blood, so they’re unlikely to interfere with drug metabolism in the liver. The risk is primarily local, in the gut, and most relevant if you’re taking other medications alongside an Epimedium supplement. Formal human drug interaction studies haven’t been completed, so the real-world significance of these interactions remains uncertain.